MODULATION OF MTORC1 ACTIVITY AND AUTOPHAGY VIA CIB2-RHEB INTERACTION Application EP-3829652-A4 European Patent Office 11 May 2022
Pharmaceutical combination of everolimus with dactolisib Grant US-10576076-B2 United States of America 03 Mar 2020
Low, immune enhancing, dose MTOR inhibitors and uses thereof Application US-10286069-B2 United States of America 14 May 2019
Low, immune enhancing, dose mtor inhibitors and uses thereof Grant US-10004803-B2 United States of America 26 Jun 2018
DEATH ASSOCIATED PROTEIN 1 VARIANTS AND USE THEREOF FOR MODULATING AUTOPHAGY Application US-20130005651-A1 United States of America 03 Jan 2013
DRUG DELIVERY COATING FOR USE WITH A MEDICAL DEVICE AND METHODS OF TREATING VASCULAR… Application US-20100034867-A1 United States of America 11 Feb 2010